Dupilumab and Atopic Dermatitis Flares: An Observational Study to Identify Common Clinical Features in Patients Who Have Exacerbations despite Biological Therapy
Restricted accessLetterFirst published online February, 2024
Dupilumab and Atopic Dermatitis Flares: An Observational Study to Identify Common Clinical Features in Patients Who Have Exacerbations despite Biological Therapy
WollenbergA, Christen-ZächS, TaiebA, et al.; European Task Force on Atopic Dermatitis/EADV Eczema Task Force. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol, 2020; 34(12):2717–2744.
MerolaJF, SidburyR, WollenbergA, et al.Dupilumab prevents flares in adults with moderate to severe atopic dermatitis in a 52-week randomized controlled phase 3 trial. J Am Acad Dermatol, 2021; 84(2):495–497.
4.
RussoF, MilanesiN, IannoneM, et al.Tuscan Consensus on the diagnosis, treatment and follow up of adult atopic dermatitis. G Ital Dermatol Venereol, 2020; 155(3):253–260.
5.
MerolaJF, SidburyR, WollenbergA, et al.Dupilumab prevents flares in adults with moderate to severe atopic dermatitis in a 52-week randomized controlled phase 3 trial. J Am Acad Dermatol, 2021; 84(2):495–497.
